Home » Topics » Regulatory

Regulatory
RSS

GlaxoSmithKline's Pandemrix H1N1 vaccine approved in Europe

Oct. 1, 2009

FDA grants accelerated approval to Allos Therapeutics' Folotyn for relapsed or refractory PTCL

Sep. 28, 2009

Abbott receives FDA approval for HIV-1/HIV-2 blood screening test

Sep. 25, 2009

Sabril launched in U.S. for patients with difficult-to-treat epilepsy

Sep. 25, 2009

FDA approves Valturna, a single-pill combination of aliskiren and valsartan

Sep. 18, 2009

Theravance and Astellas obtain FDA approval of Vibativ

Sep. 16, 2009

Lumavita is granted marketing authorization in Switzerland for pentamycin for vaginitis

Sep. 1, 2009

FDA approves Embeda for moderate to severe chronic pain

Aug. 17, 2009

Saphris approved by FDA for schizophrenia and bipolar I disorder

Aug. 17, 2009

Invega approved for the treatment of schizoaffective disorder

Aug. 6, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 6, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...